NAT10 and non-small cell lung carcinoma: GSEA and KEGG enrichment analyses suggest that abnormal expression levels of NAT10 were associated with the fatty acid metabolism pathway, implying that NAT10 may regulate lipid metabolism in NSCLC cells (Fig. 4C-D).